Camrelizumab Combined With Apatinib 、XELOX 、RFA in the Treatment of Liver Metastases of Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Oxaliplatin
Related studies linked through entity extraction aliases.
A Study to Evaluate the Safety and Efficacy of Polatuzumab Vedotin in Combination With Rituximab, Gemcitabine and Oxaliplatin Compared to Rituximab, Gemcitabine and Oxaliplatin Alone in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE1
Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Induction and Consolidation Chemotherapy in Patients With Locally Advanced CRM-positive Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Neoadjuvant Chemotherapy in Patients With Intermediate Risk Upper and Mid Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC
- Status
- UNKNOWN
- Phase
- PHASE2
Use of Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy for the Treatment of Resectable Esophageal or Gastroesophageal Junction (GEJ) Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment
- Status
- COMPLETED
- Phase
- PHASE3
Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab Plus FOLFOXIRI/Bevacizumab in First Line Chemotherapy of Advanced Colorectal Cancer RASm/BRAFm Patients
- Status
- COMPLETED
- Phase
- PHASE2
Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3